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1.  General Methods 
All reagents were purchased from commercial suppliers (Sigma-Aldrich or Fisher) and employed 
without further purification. Cyclobis(paraquat-p-phenylene) tetrakis(hexafluorophosphate)1 
(CBPQT•4PF6), S6
2 and S8•2PF6
3 were prepared according to literature procedures. Thin layer 
chromatography (TLC) was performed on silica gel 60 F254 (E. Merck). Column 
chromatography was carried out on silica gel 60F (Merck 9385, 0.040–0.063 mm). Solvents used 
in experiments involving radicals were degassed using the freeze-pump-thaw method. 
UV/Vis/NIR Spectra were recorded on a Varian 100-Bio UV-Vis spectrophotometer in MeCN at 
room temperature. Nuclear magnetic resonance (NMR) spectra were recorded on Bruker Avance 
600 or Varian P-Inova 500 spectrometers, with working frequencies of 600 and 500 MHz for 1H, 
and 150 and 125 MHz for 13C nuclei, respectively. Chemical shifts are reported in ppm relative to 
the signals corresponding to the residual non-deuterated solvents (CDCl3: δ = 7.26 ppm, CD3CN: 
δ =1.94 ppm). High resolution mass spectra were measured on a Finnigan LCQ iontrap mass 
spectrometer (HR-ESI).  
 
2.  Synthetic Procedures 
 
S1•PF6: A mixture of 3,5-lutidine (1.07 g, 10 mmol) and 1,3-dibromopropane (20 mL) was stirred 
at 120 °C overnight. After cooling to room temperature, the mixture was poured into Et2O (50 
mL). The resulting suspension was extracted with H2O (3 × 20 mL), then NH4PF6 (2 g) was 
added to the combined aqueous phase. The precipitate was filtered and washed with H2O (3 x 5 
mL) to afford S1•PF6 (3.28 g, 88%). 
1H NMR (500 MHz, CD3CN): δ 8.36 (s, 2H), 8.15 (s, 1H), 
S3 
4.54 (t, J = 7.2 Hz, 2H), 3.47 (t, J = 6.4 Hz, 2H), 2.52 – 2.47 (m 8H). 13C NMR (126 MHz, 
CD3CN): δ 147.5, 142.1, 139.8, 60.3, 33.6, 29.4, 17.9. ESI-HRMS calcd for m/z = 228.03879 [M 
– PF6]
 +, found m/z = 228.03932. 
S2•2PF6: A mixture of S1•PF6 (1.87 g, 5 mmol) and 4,4′-bipyridine (0.78 g, 5 mmol) were stirred 
in MeCN (15 mL) for 2 days. After cooling to room temperature, the mixture was poured into 
Et2O (50 mL). The resulting suspension was filtered and washed with Et2O (3 × 5 mL). The solid 
was dissolved in H2O (50 mL), then NH4PF6 (2 g) was added. The precipitate was filtered and 
washed with H2O (3 × 5 mL) to afford a crude product, which was purified by column 
chromatography (SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion 
exchange (NH4PF6 / H2O) to afford S2•2PF6 (1.35 g, 45%) as a white solid. 
1H NMR (500 MHz, 
CD3CN): δ 8.86 (d, J = 6.2 Hz, 2H), 8.77 (d, J = 6.7 Hz, 2H), 8.40 – 8.33 (m, 4H), 8.19 (s, 1H), 
7.80 (d, J = 6.3 Hz, 2H), 4.64 (t, J = 7.6 Hz, 2H), 4.54 (t, J = 7.6 Hz, 2H), 2.64 (p, J = 7.2 Hz, 
2H), 2.49 (s, 6H). 13C NMR (126 MHz, CD3CN): δ 155.3, 151.8, 147.8, 145.6, 142.0, 141.6, 
140.0, 126.9, 122.4, 58.3 (2×C), 32.2, 18.0. ESI-HRMS calcd for m/z = 450.15338 [M – PF6]
 +, 
found m/z = 450.15382. 
 
 
 
DB0•4PF6: A mixture of S1•PF6 (185 mg, 0.5 mmol) and 4,4′-bipyridine (30 mg, 0.19 mmol) 
were stirred in MeCN (1 mL) for 7 days. After cooling to room temperature, the mixture was 
poured into Et2O (50 mL). The resulting suspension was filtered and washed with Et2O (3 × 5 
S4 
mL). The solid was dissolved in H2O (50 mL), and then NH4PF6 (2 g) was added. The precipitate 
was filtered and washed with H2O (3 × 5 mL) to afford a crude product, which was purified by 
column chromatography (SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by 
counterion exchange (NH4PF6 / H2O) to afford S3•4PF6 (1.35 g, 45%) as a colorless solid. 
1H 
NMR (500 MHz, CD3CN): δ 8.91 (d, J = 6.9 Hz, 4H), 8.44 (d, J = 6.9 Hz, 4H), 8.38 (s, 4H), 8.20 
(s, 2H), 4.70 (t, J = 8.0 Hz, 4H), 4.55 (d, J = 7.9 Hz, 4H), 2.71 – 2.59 (m, 4H), 2.50 (s, 12H). 13C 
NMR (126 MHz, CD3CN): δ 150.0, 146.9, 145.5, 141.1, 139.1, 127.2, 58.0, 57.3, 31.3, 17.1. 
ESI-HRMS calcd for m/z = 889.20213 [M – PF6]
 +, found m/z = 889.20283. 
 
 
S5 
S3: A mixture of 2,6-diisopropylphenol (1.78 g, 10 mmol), 6-chlorohexan-1-ol (1.36 g, 10 mmol) 
and K2CO3 (3.0 g, 22 mmol) was stirred at 100 °C in DMF (30 mL) overnight. After cooling to 
room temperature, the mixture was poured into H2O (100 mL). The resulting mixture was 
extracted with CH2Cl2 (3 × 30 mL) and the combined organic phases were washed with saturated 
aqueous NaCl solution (100 mL). After drying (MgSO4), the solvent was removed in vacuo to 
afford a crude precursor (2.6 g) as a light-yellow oil. The crude precursor alcohol, 
p-toluenesulfonyl chloride (2.0 g, 10.5 mmol) and 4-dimethylaminopyridine (122 mg, 1 mmol) 
were stirred in Et3N (5 mL) and CH2Cl2 (50 mL) at room temperature for 3 h. The solution was 
poured into H2O (50 mL). The resulting mixture was extracted with CH2Cl2 (3 × 30 mL) and the 
combined organic phases were washed with saturated aqueous NaCl solution (50 mL). After 
drying (MgSO4), the solvent was removed in vacuo and the resulting residue was purified by 
column chromatography (SiO2: Hexanes / EtOAc 5:1) to afford S3 (3.0 g, 69%). 
1H NMR (500 
MHz, CDCl3) δ 7.80 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 7.9 Hz, 2H), 7.17 – 6.99 (m, 3H), 4.06 (t, J 
= 6.4 Hz, 2H), 3.69 (t, J = 6.4 Hz, 2H), 3.27 (hept, J = 6.9 Hz, 2H), 2.44 (s, 3H), 1.82 – 1.74 (m, 
2H), 1.71 (p, J = 6.7 Hz, 2H), 1.52 – 1.45 (m, 2H), 1.42 (m, 2H), 1.21 (d, J = 6.9 Hz, 12H). 13C 
NMR (126 MHz, CDCl3) δ 153.3, 144.7, 141.8, 133.2, 129.8, 127.9, 124.4, 123.9, 74.5, 70.5, 
30.2, 28.9, 26.4, 25.6, 25.4, 24.1, 21.7. ESI-HRMS calcd for m/z = 432.23343 [M + H] +, found 
m/z = 432.23356. 
 
DB1•3PF6: A mixture of S2•2PF6 (100 mg, 0.17 mmol) and S3 (100 mg, 0.23 mmol) was stirred 
at 80 °C in MeCN (1 mL) for 3 days. After cooling to room temperature, the solvent was 
removed under reduced pressure. The resulting residue was purified by column chromatography 
(SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion exchange (NH4PF6 / 
H2O) to afford DB1•3PF6 (100 mg, 60%). 
1H NMR (500 MHz, CD3CN): δ 8.94 – 8.89 (m, 4H), 
8.42 (d, J = 6.9 Hz, 2H), 8.40 – 8.36 (m, 4H), 8.21 (s, 1H), 7.14 – 7.05 (m, 3H), 4.69 (t, J = 8.0 
S6 
Hz, 2H), 4.65 (t, J = 7.5 Hz, 2H), 4.55 (t, J = 7.5 Hz, 2H), 3.73 (t, J = 6.4 Hz, 2H), 3.30 (hept, J = 
6.9 Hz, 2H), 2.65 (p, J = 7.2 Hz, 2H), 2.50 (s, 6H), 2.11 – 2.03 (m, 2H), 1.87 – 1.76 (m, 2H), 1.61 
(m, 2H), 1.53 – 1.44 (m, 2H), 1.19 (d, J = 6.9 Hz, 12H). 13C NMR (126 MHz, CD3CN): δ 153.9, 
151.1, 150.3, 147.8, 146.4, 146.2, 142.4, 142.0, 140.1, 128.1, 127.8, 125.1, 124.6, 75.0, 62.7, 
58.9, 58.2, 32.2, 31.5, 30.4, 26.8, 26.1, 25.9, 23.9, 18.0. ESI-HRMS calcd for m/z = 856.33940 
[M – PF6]
 +, found m/z = 856.34062. 
 
S4: A mixture of 2,6-diisopropylphenol (1.78 g, 10 mmol), 8-bromooctan-1-ol (2.2 g, 11 mmol) 
and K2CO3 (1.5 g, 11 mmol) was stirred at 80 °C in DMF (30 mL) overnight. After cooling to 
room temperature, the mixture was poured into H2O (100 mL). The resulting mixture was 
extracted with CH2Cl2 (3 x 30 mL) and the combined organic phases were washed with saturated 
aqueous NaCl solution (100 mL). After drying (MgSO4), the solvent was removed in vacuo to 
afford a crude precursor as a light-yellow oil. The crude precursor alcohol, p-toluenesulfonyl 
chloride (2.0 g, 10.5 mmol) and 4-dimethylaminopyridine (122 mg, 1 mmol) were stirred in Et3N 
(5 mL) and CH2Cl2 (50 mL) at room temperature for 3 h. The solution was poured into H2O (50 
mL). The resulting mixture was extracted with CH2Cl2 (3 × 30 mL) and the combined organic 
phases were washed with saturated aqueous NaCl solution (50 mL). After drying (MgSO4), the 
solvent was removed in vacuo and the resulting residue was purified by column chromatography 
(SiO2: Hexanes / EtOAc 5:1) to afford S4 (2.61 g, 57%). 
1H NMR (500 MHz, CDCl3) δ 7.80 (d, J 
= 8.3 Hz, 2H), 7.35 (d, J = 8.3 Hz, 2H), 7.12 – 7.04 (m, 3H), 4.04 (t, J = 6.5 Hz, 2H), 3.71 (t, J = 
6.6 Hz, 2H), 3.30 (hept, J = 6.9 Hz, 2H), 2.45 (s, 3H), 1.84 – 1.75 (m, 2H), 1.70 – 1.60 (m, 2H), 
1.51 – 1.41 (m, 2H), 1.37 – 1.27 (m, 6H), 1.22 (d, J = 6.9 Hz, 12H). 13C NMR (126 MHz, CDCl3) 
δ 153.4, 144.6, 141.8, 133.3, 129.8, 127.9, 124.3, 123.9, 74.8, 70.6, 30.4, 29.3, 28.9, 28.8, 26.4, 
26.0, 25.3, 24.1, 21.6. ESI-HRMS calcd for m/z = 460.26473 [M + H] +, found m/z = 460.26455.  
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DB2•3PF6: A mixture of S2•2PF6 (100 mg, 0.17 mmol) and S4 (100 mg, 0.22 mmol) was stirred 
at 80 °C in MeCN (1 mL) for 3 days. After cooling to room temperature, the solvent was 
removed in vacuum. The resulting residue was purified by column chromatography ((SiO2 : 
MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion exchange (NH4PF6 / H2O) to 
afford DB2•3PF6 (131 mg, 76%). 
1H NMR (500 MHz, CD3CN): δ 8.95 – 8.89 (m, 4H), 8.42 (d, J 
= 6.0 Hz, 2H), 8.41 – 8.36 (m, 4H), 8.20 (s, 1H), 7.15 – 7.03 (m, 3H), 4.71 (t, J = 7.5 Hz, 2H), 
4.63 (t, J = 7.3 Hz, 2H), 4.56 (t, J = 7.5 Hz, 2H), 3.72 (t, J = 6.4 Hz, 2H), 3.30 (hept, J = 6.9 Hz, 
2H), 2.73 – 2.58 (m, 2H), 2.50 (s, 6H), 2.09 – 1.98 (m, 2H), 1.85 – 1.74 (m, 2H), 1.57 – 1.48 (m, 
2H), 1.46 – 1.38 (m, 6H), 1.19 (d, J = 6.9 Hz, 12H). 13C NMR (126 MHz, CD3CN): δ 153.0, 
150.1, 149.3, 146.9, 145.5, 145.2, 141.4, 141.1, 139.1, 127.1, 126.9, 124.2, 123.6, 74.2, 61.8, 
57.9, 57.3, 31.3, 30.7, 29.7, 28.6, 28.3, 25.8, 25.4, 25.2, 23.0, 17.1. ESI-HRMS calcd for m/z = 
S8 
884.37070 [M – PF6]
 +, found m/z = 884.37143. 
 
S5: A mixture of 2,6-diisopropylphenol (3.56 g, 20 mmol), 11-bromo-1-undecanol (5.1 g, 20 
mmol) and K2CO3 (3 g, 22 mmol) was stirred at 80 °C in DMF (30 mL) overnight. After cooling 
to room temperature, the mixture was poured into H2O (100 mL). The resulting mixture was 
extracted with CH2Cl2 (3 × 30 mL) and the combined organic phases were washed with saturated 
aqueous NaCl solution (100 mL). After drying (MgSO4), the solvent was removed in vacuo to 
afford a crude precursor as a light-yellow oil. The crude precursor alcohol, p-toluenesulfonyl 
chloride (4.0 g, 21 mmol) and 4-dimethylaminopyridine (122 mg, 1 mmol) was stirred in Et3N 
(10 mL) and CH2Cl2 (50 mL) at room temperature for 3 h. The solution was poured into H2O (50 
mL). The resulting mixture was extracted with CH2Cl2 (3 × 30 mL) and the combined organic 
phases were washed with saturated aqueous NaCl solution (50 mL). After drying (MgSO4), the 
solvent was removed in vacuo and the resulting residue was purified by column chromatography 
(SiO2: Hexanes / EtOAc 5:1) to afford S5 (6.94 g, 69%). 
1H NMR (500 MHz, CDCl3) 
1H NMR 
(500 MHz, CDCl3) δ 7.79 (d, J = 8.3 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 7.12 – 7.04 (m, 3H), 4.02 
(t, J = 6.5 Hz, 2H), 3.72 (t, J = 6.6 Hz, 2H), 3.31 (hept, J = 6.9 Hz, 2H), 2.45 (s, 3H), 1.87 – 1.75 
(m, 2H), 1.67 – 1.59 (m, 2H), 1.53 – 1.44 (m, 2H), 1.40 – 1.24 (m, 12H), 1.22 (d, J = 7.1 Hz, 
12H). 13C NMR (126 MHz, CDCl3) δ 153.5, 144.6, 141.8, 133.3, 129.8, 127.9, 124.3, 123.9, 
74.9, 70.7, 30.4, 29.6, 29.5, 29.5, 29.4, 29.0, 28.9, 26.4, 26.1, 25.4, 24.1, 21.7. ESI-HRMS calcd 
for m/z = 502.31168 [M + H] +, found m/z = 502.31180. 
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DB3•3PF6: A mixture of S2•2PF6 (100 mg, 0.17 mmol) and S5 (100 mg, 0.20 mmol) was stirred 
at 80 °C in MeCN (1 mL) for 3 days. After cooling to room temperature, the solvent was 
removed under reduced pressure. The resulting residue was purified by column chromatography 
(SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion exchange (NH4PF6 / 
H2O) to afford DB3•3PF6 (61 mg, 34%). 
1H NMR (500 MHz, CD3CN): δ 8.95 (d, J = 5.4 Hz, 
2H), 8.93 (d, J = 6.9 Hz, 2H), 8.45 (d, J = 6.9 Hz, 2H), 8.43 (s, 2H), 8.41 (d, J = 6.4 Hz, 2H), 
8.23 (s, 1H), 7.17 – 7.06 (m, 3H), 4.73 (t, J = 8.0 Hz, 2H), 4.64 (t, J = 7.6 Hz, 2H), 4.59 (t, J = 
7.5 Hz, 2H), 3.74 (t, J = 6.4 Hz, 2H), 3.34 (hept, J = 6.9 Hz, 2H), 2.75 – 2.62 (m, 2H), 2.53 (s, 
6H), 2.09 – 2.00 (m, 2H), 1.88 – 1.76 (m, 2H), 1.54 (p, J = 6.8 Hz, 2H), 1.46 – 1.34 (m, 12H), 
S10 
1.22 (d, J = 6.9 Hz, 12H). 13C NMR (126 MHz, CD3CN): δ 153.0, 150.1, 149.3, 146.9, 145.5, 
145.2, 141.4, 141.1, 139.1, 127.1, 126.8, 124.1, 123.6, 74.2, 61.8, 57.9, 57.3, 31.3, 30.7, 29.7, 
29.0, 28.9, 28.8, 28.7, 28.3, 25.8, 25.4, 25.2, 23.0, 17.1. ESI-HRMS calcd for m/z = 926.41765 
[M – PF6]
 +, found m/z = 926.41847. 
 
 
 
DB4•3PF6: A mixture of S2•2PF6 (100 mg, 0.17 mmol) and S6
2 (100 mg, 0.22 mmol) was stirred 
at 80 °C in MeCN (1 mL) for 3 days. After cooling to room temperature, the solvent was 
removed under reduced pressure. The resulting residue was purified by column chromatography 
(SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion exchange (NH4PF6 / 
H2O) to afford DB4•3PF6 (101 mg, 58%). 
1H NMR (500 MHz, CD3CN): δ 8.99 (d, J = 6.9 Hz, 
2H), 8.86 (d, J = 6.4 Hz, 2H), 8.39 (s, 2H), 8.34 (d, J = 6.5 Hz, 2H), 8.29 (d, J = 6.3 Hz, 2H), 
8.20 (s, 1H), 7.17 – 7.06 (m, 3H), 4.80 (t, J = 4.8 Hz, 2H), 4.69 (t, J = 7.6 Hz, 2H), 4.55 (t, J = 
S11 
7.5 Hz, 2H), 4.03 (t, J = 4.3 Hz, 2H), 3.90 – 3.86 (m, 2H), 3.80 – 3.76 (m, 2H), 3.74 – 3.70 (m, 
2H), 3.69 – 3.64 (m, 2H), 3.37 (hept, J = 6.9 Hz, 2H), 2.69 – 2.60 (m, 2H), 2.50 (s, 6H), 1.15 (d, 
J = 6.9 Hz, 12H). 13C NMR (126 MHz, CD3CN): δ 153.5, 151.0, 150.4, 147.8, 146.9, 146.3, 
142.4, 142.0, 140.0, 128.0, 127.3, 125.4, 124.8, 74.4, 70.9, 70.7, 69.2, 62.2, 58.9, 58.2, 32.3, 
26.5, 23.9, 18.0. ESI-HRMS calcd for m/z = 888.32923 [M – PF6]
 +, found m/z = 888.32947. 
 
 
 
S7: A mixture of 2,6-diisopropylphenol (0.52 g, 2.9 mmol), tetraethylene glycol monotosylate 
(1.0 g, 2.9 mmol) and K2CO3 (0.7 g, 5 mmol) was stirred at 80 °C in DMF (20 mL) overnight. 
After cooling to room temperature, the mixture was poured into H2O (100 mL). The resulting 
mixture was extracted with CH2Cl2 (3 × 30 mL) and the combined organic phases were washed 
S12 
with saturated aqueous NaCl solution (100 mL). After drying (MgSO4), the solvent was removed 
in vacuo to afford the crude alcohol as a light-yellow oil. This crude precursor alcohol, 
p-toluenesulfonyl chloride (0.57 g, 3 mmol) and 4-dimethylaminopyridine (20 mg, 0.16 mmol) 
were stirred in Et3N (5 mL) and CH2Cl2 (30 mL) at room temperature for 3 h. The solution was 
poured into H2O (50 mL). The resulting mixture was extracted with CH2Cl2 (3 × 30 mL) and the 
combined organic phases were washed with saturated aqueous NaCl solution (50 mL). After 
drying (MgSO4), the solvent was removed in vacuo and the resulting residue was purified by 
column chromatography (SiO2: Hexanes / EtOAc 1:1) to afford S7 (0.58 g, 40%). 
1H NMR (500 
MHz, CDCl3) δ 7.80 (d, J = 8.3 Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 7.09 (s, 3H), 4.16 (t, J = 5.0 
Hz, 2H), 3.93 – 3.89 (m, 2H), 3.87 – 3.82 (m, 2H), 3.77 – 3.72 (m, 2H), 3.72 – 3.67 (m, 4H), 3.66 
– 3.62 (m, 2H), 3.62 – 3.58 (m, 2H), 3.37 (hept, J = 6.9 Hz, 2H), 2.44 (s, 3H), 1.21 (d, J = 6.9 Hz, 
12H). 13C NMR (126 MHz, CDCl3) δ 153.0, 144.8, 141.8, 132.9, 129.8, 128.0, 124.6, 124.0, 
73.8, 71.0, 70.8, 70.8, 70.7, 70.6, 69.2, 68.7, 26.2, 24.2, 21.7. ESI-HRMS calcd for m/z = 
508.24947 [M + H] +, found m/z = 508.25053. 
 
DB5•3PF6: A mixture of S2•2PF6 (100 mg, 0.17 mmol) and S7 (150 mg, 0.29 mmol) was stirred 
at 80 °C in MeCN (1 mL) for 3 days. After cooling to room temperature, the solvent was 
removed under reduced pressure. The resulting residue was purified by column chromatography 
(SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion exchange (NH4PF6 / 
H2O) to afford DB5•3PF6 (39 mg, 21%). 
1H NMR (500 MHz, CD3CN): δ 9.00 (d, J = 7.0 Hz, 
2H), 8.91 (d, J = 6.7 Hz, 2H), 8.44 (d, J = 7.0 Hz, 2H), 8.43 – 8.39 (m, 4H), 8.24 (s, 1H), 7.18 – 
7.07 (m, 3H), 4.81 (t, J = 5.9 Hz, 2H), 4.71 (t, J = 7.6 Hz, 2H), 4.58 (t, J = 7.5 Hz, 2H), 4.03 (t, J 
= 5.0 Hz, 2H), 3.91 – 3.87 (m, 2H), 3.83 – 3.79 (m, 2H), 3.73 – 3.67 (m, 4H), 3.67 – 3.60 (m, 
4H), 3.39 (hept, J = 6.9 Hz, 2H), 2.72 – 2.62 (m, 2H), 2.53 (s, 6H), 1.19 (d, J = 6.9 Hz, 12H). 13C 
NMR (126 MHz, CD3CN): δ 152.6, 150.2, 149.5, 146.9, 146.0, 145.4, 141.5, 141.1, 139.1, 127.1, 
S13 
126.4, 124.5, 123.8, 73.6, 70.1, 70.0, 69.8, 69.8, 69.7, 68.2, 61.3, 57.9, 57.3, 31.3, 25.6, 23.0, 
17.1. ESI-HRMS calcd for m/z = 932.35544 [M – PF6]
 +, found m/z = 932.35600. 
 
 
 
DB8•3PF6: A mixture of S8•2PF6
3 (100 mg, 0.17 mmol) and S3 (100 mg, 0.23 mmol) was stirred 
at 80 °C in MeCN (1 mL) for 3 days. After cooling to room temperature, the solvent was 
removed under reduced pressure. The resulting residue was purified by column chromatography 
(SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion exchange (NH4PF6 / 
H2O) to afford DB8•3PF6 (100 mg, 60%). 
1H NMR (500 MHz, CD3CN): δ 8.96 (d, J = 6.9 Hz, 
2H), 8.90 (d, J = 6.9 Hz, 2H), 8.47 (d, J = 6.9 Hz, 2H), 8.45 – 8.40 (m, 4H), 8.30 (s, 1H), 7.18 – 
7.07 (m, 3H), 5.20 (t, J = 6.6 Hz, 2H), 5.05 (t, J = 6.6 Hz, 2H), 4.68 (t, J = 7.5 Hz, 2H), 3.76 (t, J 
= 6.4 Hz, 2H), 3.33 (hept, J = 6.9 Hz, 2H), 2.52 (s, 6H), 2.15 – 2.07 (m, 2H), 1.89 – 1.79 (m, 2H), 
S14 
1.68 – 1.59 (m, 2H), 1.56 – 1.48 (m, 2H), 1.22 (d, J = 6.9 Hz, 12H). 13C NMR (126 MHz, 
CD3CN): δ 154.3, 152.4, 150.5, 149.4, 147.2, 146.7, 142.8, 142.8, 141.0, 128.9, 128.3, 125.6, 
125.0, 75.4, 63.2, 60.9, 60.3, 31.9, 30.8, 27.2, 26.6, 26.3, 24.3, 18.4. ESI-HRMS calcd for m/z = 
842.32375 [M – PF6]
 +, found m/z = 842.32450. 
 
 
 
DB7•3PF6: A mixture of S8•2PF6
3 (100 mg, 0.17 mmol) and S4 (100 mg, 0.22 mmol) was stirred 
at 80 °C in MeCN (1 mL) for 3 days. After cooling to room temperature, the solvent was 
removed under reduced pressure. The resulting residue was purified by column chromatography 
(SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion exchange (NH4PF6 / 
H2O) to afford DB7•3PF6 (118 mg, 67%). 
1H NMR (500 MHz, CD3CN): δ 8.92 (d, J = 6.3 Hz, 
2H), 8.82 (d, J = 6.6 Hz, 2H), 8.44 (d, J = 6.4 Hz, 2H), 8.39 (d, J = 6.3 Hz, 2H), 8.36 (s, 2H), 
8.27 (s, 1H), 7.16 – 7.03 (m, 3H), 5.16 (t, J = 6.5 Hz, 2H), 5.01 (t, J = 6.5 Hz, 2H), 4.64 (t, J = 
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7.6 Hz, 2H), 3.73 (t, J = 6.4 Hz, 2H), 3.31 (hept, J = 6.9 Hz, 2H), 2.49 (s, 6H), 2.09 – 2.01 (m, 
2H), 1.84 – 1.77 (m, 2H), 1.59 – 1.49 (m, 2H), 1.47 – 1.39 (m, 6H), 1.19 (d, J = 6.9 Hz, 12H). 13C 
NMR (126 MHz, CD3CN): δ 154.4, 152.4, 150.5, 149.5, 147.1, 146.7, 142.8, 142.7, 141.0, 128.9, 
128.3, 125.5, 125.0, 75.6, 63.2, 60.9, 60.4, 32.0, 31.0, 29.9, 29.6, 27.2, 26.7, 26.6, 24.3, 18.4. 
ESI-HRMS calcd for m/z = 870.35505 [M – PF6]
 +, found m/z = 870.35505. 
 
 
 
S10•2PF6: A mixture of 3,5-lutidine (1.07 g, 10 mmol) and 1,4-dibromobutane (10 mL) was 
stirred at 120 °C overnight. After cooling to room temperature, the mixture was poured into Et2O 
(50 mL). The resulting suspension was extract with H2O (3 × 20 mL), then NH4PF6 (2 g) was 
added to the combined water phase. The precipitate was filtered and washed with H2O (3 × 5 mL) 
to afford S9•PF6 (3.45 g, 89%). A mixture of S9•PF6 (3.0 g, 7.7 mmol) and 4,4′-bipyridine (1.0 g, 
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6.4 mmol) were stirred in MeCN (10 mL) for 3 days. After cooling to room temperature, the 
mixture was poured into Et2O (50 mL). The resulting suspension was filtered and washed with 
Et2O (3 × 5 mL). The solid was dissolved in H2O (50 mL), then NH4PF6 (2 g) was added. The 
precipitate was filtered and washed with H2O (3 × 5 mL) to afford a crude product, which was 
purified by column chromatography (SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed 
by counterion exchange (NH4PF6 / H2O) to afford S10•2PF6 (2.07 g, 54%) as a white solid. 
1H 
NMR (500 MHz, CD3CN): δ 8.91 – 8.86 (m, 2H), 8.77 (d, J = 6.9 Hz, 2H), 8.39 – 8.33 (m, 4H), 
8.18 (d, J = 5.6 Hz, 1H), 7.82 (d, J = 6.2 Hz, 2H), 4.59 (t, J = 5.8 Hz, 2H), 4.47 (t, J = 5.9 Hz, 
2H), 2.49 (s, 6H), 2.07 – 2.01 (m, 4H). 13C NMR (126 MHz, CD3CN): δ 154.0, 150.8, 146.5, 
144.6, 140.9, 140.8, 138.8, 125.7, 121.4, 60.1 (2×C), 26.9, 26.7, 17.0. ESI-HRMS calcd for m/z = 
464.16903 [M – PF6]
 +, found m/z = 464.16962. 
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DB6•3PF6: A mixture of S18•2PF6 (100 mg, 0.17 mmol) and S4 (100 mg, 0.22 mmol) was stirred 
at 80 °C in MeCN (1 mL) for 3 days. After cooling to room temperature, the solvent was 
removed under reduced pressure. The resulting residue was purified by column chromatography 
(SiO2 : MeOH / NH4Cl (aq, 2M) / MeNO2 = 7:2:1), followed by counterion exchange (NH4PF6 / 
H2O) to afford DB6•3PF6 (154 mg, 90%). 
1H NMR (500 MHz, CD3CN): δ 8.93 (d, J = 7.0 Hz, 
2H), 8.91 (d, J = 6.9 Hz, 2H), 8.44 – 8.39 (m, 4H), 8.38 (s, 2H), 8.19 (t, J = 6.5 Hz, 1H), 7.18 – 
7.08 (m, 3H), 4.73 – 4.60 (m, 4H), 4.49 (t, J = 6.5 Hz,2H), 3.75 (t, J = 6.4 Hz, 2H), 3.33 (hept, J 
= 6.9 Hz, 2H), 2.50 (s, 6H), 2.12 – 2.02 (m, 6H), 1.88 – 1.76 (m, 2H), 1.59 – 1.53 (m, 2H), 1.48 – 
1.43 (m, 6H), 1.22 (d, J = 6.9 Hz, 12H). 13C NMR (126 MHz, CD3CN): δ 153.0, 149.8, 149.4, 
146.5, 145.3, 145.2, 141.4, 141.0, 138.8, 126.9, 126.8, 124.2, 123.6, 74.2, 61.8, 60.7, 60.0, 30.7, 
29.7, 28.6, 28.3, 27.0, 26.7, 25.8, 25.4, 25.2, 23.0, 17.0. ESI-HRMS calcd for m/z = 898.38635 
[M – PF6]
 +, found m/z = 898.38755. 
 
S11•7PF6: DB7•3PF6 (30 mg, 0.03 mmol) and CBPQT•4PF6 (35 mg, 0.033 mmol) were 
dissolved in MeCN (20 mL, degassed). An excess of activated Zn dust was added to the solution 
in a glovebox. After stirring for 30 min, the mixture was filtered and NOPF6 (20 mg, 0.11 mmol) 
was added. The mixture was analyzed by HPLC-MS before being purified by column 
chromatography (C18-functionalized SiO2: H2O / MeCN with 0.1% CF3COOH). The product 
containing fractions were combined, an excess of NH4PF6 was added and the organic solvent was 
evaporated under reduced pressure. The resulting precipitate was collected by filtration, washed 
with copious amounts H2O, and dried under high vacuum to afford S11•7PF6 (30 mg, 50%) as a 
colorless solid. 1H NMR (500 MHz, CD3CN): δ 9.17 – 8.99 (m, 10H), 8.86 (d, J = 6.3 Hz, 2H), 
8.57 – 8.55 (m, 4H), 8.44 (b, 8H), 8.38 (s, 2H), 8.29 (s, 1H), 7.62 (s, 8H), 7.33 – 7.16 (m, 3H), 
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5.84 (dd, J = 22.7, 13.8 Hz, 8H), 5.20 (t, J = 6.4 Hz, 2H), 5.04 (t, J = 6.6 Hz, 2H), 4.63 (t, J = 8.0 
Hz, 2H), 3.01 – 2.96 (m, 4H), 2.51 (s, 6H), 1.67 – 1.57 (m, 2H), 1.47 (d, J = 7.0 Hz, 12H), 0.57 
(b, 2H), –1.24 (b, 2H), –1.45 (b, 2H), –1.68 (b, 4H). 13C NMR (126 MHz, CD3CN): δ 153.0, 
152.1, 150.2, 149.1, 148.7, 146.8, 146.3 (2×C), 142.3, 141.8, 140.7, 136.8, 131.0, 128.6, 128.0, 
127.8, 126.0, 125.2, 74.8, 65.3, 62.4, 60.6, 60.0, 31.6, 30.4, 29.8, 29.6, 26.9 (2×C), 26.5, 24.5, 
18.0. ESI-HRMS calcd for m/z = 912.75460 [M – 2PF6]
 2+, found m/z = 912.75481.  
 
Figure S1. Analytical HPLC trace of a) DB7•3PF6 and CBPQT•4PF6 immediately after 
the reduction and oxidation procedure, b) DB7•3PF6 and c) CBPQT•4PF6   
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3. UV/Vis/NIR Spectroscopy 
DB0•4PF6 (1.0 mg, 0.001 mmol) or CBPQT•4PF6 (1.1 mg, 0.001 mmol) was dissolved in MeCN 
(10 mL, degassed). Excess of activated Zn dust was added to it and stirred for 10 min in a 
glovebox. The solution changed to blue in seconds. The UV/Vis/NIR spectrum was recorded after 
filtering. A mixture of DB0•4PF6 (1.0 mg, 0.001 mmol) and CBPQT•4PF6 (1.1 mg, 0.001 mmol) 
was dissolved in MeCN (10 mL, degassed). Excess of activated Zn dust was added to the mixture 
and it was stirred for 10 min in a glovebox. The solution changed to blue then purple in seconds. 
The UV/Vis/NIR spectrum was recorded after filtering. 
 
Figure S2. UV/Vis/NIR Spectra of DB03+• (black trace), CBPQT2(+•) (blue trace), 
DB03+•⊂CBPQT2(+•) (purple trace). The broad peak around 1100 nm indicates formation 
of a trisradical complex4. [CBPQT4+] = 1.0 × 10−4 M. [DB04+] = 1.0 × 10−4 M. 
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4. Single Crystal X-Ray Diffraction 
Excess of activated zinc dust was added to a mixture of DB0•4PF6 (1.0 mg, 1.0 µmol) and 
CBPQT•4PF6 (1.1 mg, 1.0 µmol) in MeCN (1 mL) in a glovebox, and the mixture was stirred for 
30 min. After filtering, the purple solution was kept under an atmosphere of iPr2O at 0 °C to 
allow slow vapor diffusion to occur. Single crystals of DB0⊂CBPQT•6PF6, an overall bisradical 
species, were formed after a month. They were immersed in inert oil and transferred to the cold 
gas stream of a Bruker Kappa APEX CCD area detector, equipped with a CuKα microsource with 
MX optics. A SADABS-2008/1 (Bruker,2008) was used for absorption correction. wR2(int) was 
0.0952 before and 0.0331 after correction. The ratio of minimum to maximum transmission was 
0.8222. The λ/2 correction factor is not present. 
 
Figure S3. Crystal structure of DB0⊂CBPQT•6PF6 a) top view, b) and c) side views, d) 
space filling representation. Solvent molecules and counter ions are omitted for clarity.  
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Crystal Data for C82H94F36N16P6, M =2173.55, monoclinic, a = 18.8758(10), b = 20.3394(13), c 
= 13.1067(8), β = 104.883(3)°, V = 4863.1(5) Å3, T = 99.98, space group P21/c (no. 14), Z = 2, 
µ(CuKα) = 2.114, 30255 reflections measured, 8210 unique (Rint = 0.0327) which were used in 
all calculations. The final wR(F2) was 0.1898 (all data), R1 = 0.0696 for I > 2σ(I). No special 
refinement necessary. Crystallographic data (excluding structure factors) for the structures 
reported in this communication have been deposited with the Cambridge Crystallographic Data 
Center as supplementary publication no. CCDC–1019889. 
It is worth highlighting that the solid-state structures contains 6 hexafluorophosphate anions, 
indicating the inclusion complex is not a trisradical complex as we observed by UV/Vis/NIR 
spectroscopy in solution. Possible reasons for this unexpected phenomenon might be that: (i) the 
trace amount of oxygen in glovebox (< 10 ppm) oxidized the trisradical specials as the crystals 
were growing slowly over a month, (ii) both trisradical and bisradical crystals formed, but, the 
crystal of the trisradical could be not distinguishable from the bisradical (in term of morphology), 
crystals of C82H94F36N16P6 were chosen for crystallography, or (iii) the bisradical state may 
crystallize preferentially as has been witnessed previously.5 Although unexpected, this 
experimental observation is still in keeping with the formation of the trisradical inclusion 
complex that we observe spectroscopically in solution.  
 
5. 1H NMR Spectroscopy Investigation of Pumping and Dethreading 
General procedure for pumping and dethreading experiments: The dumbbell (DB1•3PF6, 
DB2•3PF6, DB3•3PF6, DB4•3PF6, DB5•3PF6, DB6•3PF6, DB7•3PF6, or DB8•3PF6, 0.001 mmol) 
and CBPQT•4PF6 (1.1 mg, 0.001 mmol) were dissolved in CD3CN (0.75 mL, degassed). Excess 
of Zn dust was added to the solution in a glovebox. The solution changes quickly to a deep blue 
color and then to purple in seconds. After stirring for 5 min, the mixture is filtered and 
tris(4-bromophenyl)aminium hexachloridoantimonate (Magic Blue)(5 mg, 0.006 mmol) is added 
at 0 °C, causing the solution to change color quickly to deep blue. The resulting solution is sealed 
in an NMR tube and analyzed by 1H NMR spectroscopy.  
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Figure S4. 1H NMR Spectra (recorded in CD3CN) of a) DB1•3PF6, b) DB1•3PF6 and 
CBPQT•4PF6 immediately after the reduction and oxidation procedures, and c) after 4 h 
at 6 °C, and d) CBPQT•4PF6. e)
 1H NMR Spectra recorded at 6 °C over 4 h. (f) The 
change in the molar ratio with time based on 1H NMR integration. The inset shows a 
linear relationship between –ln(c/c0) and time, indicating that the dethreading obeys first 
order kinetics. The activation barrier ∆G≠ was calculated using the Eyring equation. 
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Figure S5. 1H NMR spectra (recorded in CD3CN) of a) DB2•3PF6, b) DB2•3PF6 and 
CBPQT•4PF6 immediately after the reduction and oxidation procedures, and c) after 3 h 
at 58 °C, and d) CBPQT•4PF6. e)
 1H NMR Spectra recorded at 58 °C over 3 h. (f) The 
change in the molar ratio with time based on 1H NMR integration. The inset shows a 
linear relationship between –ln(c/c0) and time, indicating that the dethreading obeys first 
order kinetics. The activation barrier ∆G≠ was calculated using the Eyring equation. 
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Figure S6. 1H NMR Spectra (recorded in CD3CN) of a) DB3•3PF6, b) DB3•3PF6 and 
CBPQT•4PF6 immediately after the reduction and oxidation procedures, and c) after 14 h 
at 92 °C, and d) CBPQT•4PF6. e)
 1H NMR Spectra recorded at 92 °C over 14 h. (f) The 
change in the molar ratio with time based on 1H NMR integration. The inset shows a 
linear relationship between –ln(c/c0) and time, indicating that the dethreading obeys first 
order kinetics. The activation barrier ∆G≠ was calculated using the Eyring equation. 
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Figure S7. 1H NMR Spectra (recorded in CD3CN) of a) DB4•3PF6, b) DB4•3PF6 and 
CBPQT•4PF6 immediately after the reduction and oxidation procedures, and c) after 6 h 
at 44 °C, and d) CBPQT•4PF6. e)
 1H NMR Spectra recorded at 44 °C over 6 h. (f) The 
change in the molar ratio with time based on 1H NMR integration. The inset shows a 
linear relationship between –ln(c/c0) and time, indicating that the dethreading obeys first 
order kinetics. The activation barrier ∆G≠ was calculated using the Eyring equation. 
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Figure S8. 1H NMR spectra (recorded in CD3CN) of a) DB5•3PF6, b) DB5•3PF6 and 
CBPQT•4PF6 immediately after the reduction and oxidation procedures, and c) after 10 h 
at 82 °C, and d) CBPQT•4PF6. e)
 1H NMR Spectra recorded at 82 °C over 10 h. (f) The 
change in the molar ratio with time based on 1H NMR integration; the S shape curve 
indicating the dethreading is indicative of an auto-catalytic process. 
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Figure S9. 1H NMR Spectra (CD3CN, 298 K) of a) DB6•3PF6, b) DB6•3PF6 and 
CBPQT•4PF6 immediately after the reduction and oxidation procedures, and c) 
CBPQT•4PF6. No obvious shifts were identified indicating that the spectrum b) is a 
simple physical mixture of DB6•3PF6 and CBPQT•4PF6 
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Figure S10. 1H NMR Spectra (recorded in CD3CN) of a) DB7•3PF6, b) DB7•3PF6 and 
CBPQT•4PF6 immediately after the reduction and oxidation procedures, and c) after 18 h 
at 82 °C, and d) CBPQT•4PF6. The spectrum of the mixture of DB7•3PF6 and 
CBPQT•4PF6 after the reduction and oxidation procedure does not change at high 
temperature over several hours (cf. b and c) indicating the dethreading barrier for 
CBPQT4+ is high. Additional peaks in aromatic area are attributed to the decomposition of 
Magic Blue upon subjecting to high temperature over an extended period of time.  
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Figure S11. 1H NMR Spectra (recorded in CD3CN) of a) DB8•3PF6, b) DB8•3PF6 and 
CBPQT•4PF6 immediately after the reduction and oxidation procedures, and c) after 16 h 
at 82 °C, d) CBPQT•4PF6. e)
 1H NMR Spectra recorded at 82 °C over 16 h. (f) The 
change in the molar ratio with time based on 1H NMR integration. The inset shows a 
linear relationship between –ln(c/c0) and time, indicating that the dethreading obeys first 
order kinetics. The activation barrier ∆G≠ was calculated using the Eyring equation. 
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Table S1. Summary of Thermodynamic Data. 
Compound 
Dethreading rate constant 
k / 10-5 s-1 (Temperature / K) 
Activation barrier 
a
 
∆G
≠ / kcal mol-1 
Half life time 
b
 
 t1/2 at 298 K / h 
DB1•3PF6 8.4 ± 0.6 (279) 21.5 0.18 
DB2•3PF6 12 ± 1 (331) 25.3 120 
DB3•3PF6 3.3 ± 0.2 (365) 29.0 57000 
DB4•3PF6 7.8 ± 0.2 (317) 24.5 32 
DB5•3PF6 - - - 
DB6•3PF6 > 1000 (298) < 18.3 < 0.01 
DB7•3PF6 < 0.05 (355) > 31.3 > 2900000 
DB8•3PF6 2.2 ± 0.1 (355) 28.5 24000 
a Calculated using the Erying equation using the detheading rate constant. b Calculated using t1/2 = 
ln2 / k298K, where k298K is the dethreading rate constant at 298 K where can be obtained using the 
Eyring equation with ∆G‡, assuming the temperature dependence of ∆G‡ can be ignored.  
 
Table S2. Summary of Rotaxane Yield at Different Oxidization Temperatures.a 
Dumbbell 
Yield (%) 
RT 0oC ̶ 40oC 
DB7•3PF6 79 83 - 
DB2•3PF6 50 74 >95 
DB6•3PF6 0 0 <5 
a Dumbell (1.0 mg, 0.001 mmol) and CBPQT•4PF6 (1.1 mg, 0.001 mmol) was dissolved in 
CD3CN (0.75 mL, degassed). Excess of Zn dust was added to the solution in a glovebox. After 
stirring for 5 min, the mixture was filtered and tris(4-bromophenyl)aminium 
hexachloridoantimonate (Magic Blue, 5 mg, 0.006 mmol) was added at the given temperature 
before the sample was analyzed by 1H NMR at that temperature.  
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6. DFT calculations 
The geometries were optimized using the PBF Poisson-Boltzmann solvation model6 for 
acetonitrile (ɛ=37.5 and R0= 2.18 Å) at the level of M06-HF/6-31G* with Jaguar 7.9
7. The single 
point energy was refined at the level of M06-HF/6-311++G**. We assumed that two MeCN 
molecules are contained in the cavity of free CBPQT4+ in solution. The energies of DB13+, 
DB2
3+, DB33+ and corresponding CBPQT4+ rotaxanes are listed in Table S3.  
In order to obtain the potential profile for the dethreading process for DB83+ and DB93+, the 
center of the CBPQT4+ ring was scanned along each atom of the molecule. Various numbers of 
chloride anions (0–3) were placed around the molecule as counterions to accommodate better the 
change of electrostatics as a result of the motion of CBPQT4+ ring. Then the minimum energy 
was evaluated for each point along the potential profile. The barrier was calculated as the energy 
difference between the highest point in the potential profile and the rotaxane with CBPQT4+ 
optimized with no constraint at the end of diisopropylphenol (defined as freely optimized in the 
Table S4 and S11).  
The total energy is the sum of refined single point energy and solvation energy, as provided in the 
Table S4 ̶ 13. The gas phase energy is the DFT energy for a vacuum with no corrections for 
zero-point energy (ZPE). The solution phase energy includes the solute energy and half of the 
solute-solvent energy. The solvation energy is the difference between these two quantities. The 
refined single point energy is the DFT energy for a vacuum at 6-311++G** level. The difference 
between refined single point energy in column 5 and gas phase energy in column 3 is subtracted 
from solution phase energy in column 2 to give the total energy in column 6. This total energy 
does not include the effects of entropy and specific heat needed to get the free energy at the 
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temperature of the experiments. The total energy is the quantity to be used in considering the 
energy profiles. 
Table S3. The energy components of DB13+, DB23+, DB33+, CBPQT4+ and corresponding 
[2]pseudorotaxanes. 
 
solution 
phase 
energy 
gas phase 
energy 
solvation 
energy 
refined 
single point 
energy 
total energy 
DB1
3+
 -1717.915627 -1717.46068 -0.454946 -1717.918433 -1718.37338 
DB2
3+
 -1796.513915 -1796.060229 -0.453685 -1796.538531 -1796.99222 
DB3
3+
 -1914.410262 -1913.958397 -0.451865 -1914.467299 -1914.91916 
DB1
3+
⊂CBPQT
4+
 -3326.993458 -3325.360269 -1.633189 -3326.241829 -3327.87502 
DB2
3+
⊂CBPQT
4+
 -3405.602955 -3404.03155 -1.571406 -3404.932268 -3406.50367 
DB3
3+
⊂CBPQT
4+
 -3523.502404 -3522.009906 -1.492498 -3522.940921 -3524.43342 
CBPQT
4+
 -1609.101228 -1608.353963 -0.747265 -1608.770372 -1609.51764 
2CH3CN⊂CBPQT
4+ -1874.547038 -1873.80792 -0.739117 -1874.311107 -1875.05022 
CH3CN -265.4362174 -265.4159063 -0.020311 -265.5044871 -265.524798 
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Table S4. The energy components of CBPQT4+ moving on DB83+ with no Cl–. 
 
solution 
phase energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
DB8
3+
 -1678.605646 -1678.138209 -0.467437573 -1678.585992 -1679.05343 
Freely 
optimized 
-3287.684173 -3286.035138 -1.649035 -3286.906831 -3288.555865 
C1 -3287.640671 -3285.910133 -1.730538 -3286.786004 -3288.516543 
C2 -3287.632835 -3285.841534 -1.791301 -3286.719131 -3288.510432 
C3 -3287.631109 -3285.820389 -1.810720 -3286.698749 -3288.509470 
N4 -3287.631680 -3285.773063 -1.858617 -3286.657305 -3288.515922 
C5 -3287.628561 -3285.761729 -1.866832 -3286.639066 -3288.505898 
C6 -3287.619369 -3285.752630 -1.866739 -3286.630015 -3288.496754 
C7 -3287.616599 -3285.754825 -1.861774 -3286.633371 -3288.495145 
C8 -3287.611596 -3285.747270 -1.864326 -3286.627459 -3288.491785 
C9 -3287.594925 -3285.740370 -1.854555 -3286.618297 -3288.472852 
C10 -3287.585364 -3285.741071 -1.844293 -3286.619557 -3288.463850 
N11 -3287.588307 -3285.743732 -1.844575 -3286.622722 -3288.467297 
C12 -3287.587636 -3285.740688 -1.846949 -3286.621582 -3288.468530 
C13 -3287.602383 -3285.754552 -1.847831 -3286.636082 -3288.483913 
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N14 -3287.617305 -3285.773445 -1.843860 -3286.653574 -3288.497434 
C15 -3287.614383 -3285.770039 -1.844345 -3286.651124 -3288.495468 
C16 -3287.615633 -3285.780277 -1.835355 -3286.660149 -3288.495505 
Table S5. The energy components of CBPQT4+ moving on DB83+ with 1 Cl– (configuration 1) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
Cl
-
 -460.3496276 -460.2279551 -0.121672512 -460.2818989 -460.418929 
C1 -3748.006557 -3746.714496 -1.292060 -3747.653265 -3748.945326 
C2 -3747.999340 -3746.655132 -1.344208 -3747.595416 -3748.939624 
C3 -3747.999884 -3746.640569 -1.359315 -3747.582142 -3748.941457 
N4 -3747.997610 -3746.598779 -1.398832 -3747.541566 -3748.940398 
C5 -3748.003824 -3746.587069 -1.416756 -3747.530304 -3748.947059 
C6 -3747.992931 -3746.565397 -1.427535 -3747.509898 -3748.937433 
C7 -3747.987460 -3746.548395 -1.439065 -3747.499327 -3748.938392 
C8 -3747.978545 -3746.538456 -1.440089 -3747.491297 -3748.931387 
C9 -3747.981306 -3746.545953 -1.435353 -3747.488362 -3748.923715 
C10 -3747.988904 -3746.566784 -1.422120 -3747.508555 -3748.930675 
N11 -3747.980235 -3746.564116 -1.416119 -3747.506165 -3748.922284 
C12 -3748.008053 -3746.570663 -1.437389 -3747.513719 -3748.951109 
C13 -3747.992984 -3746.576974 -1.416011 -3747.521433 -3748.937444 
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N14 -3748.007000 -3746.594845 -1.412154 -3747.537920 -3748.950074 
C15 -3748.012157 -3746.599785 -1.412372 -3747.542888 -3748.955260 
C16 -3748.002847 -3746.597855 -1.404993 -3747.539502 -3748.944495 
 
Table S6. The energy components of CBPQT4+ moving on DB83+ with 1 Cl–.(configuration 2) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -3747.954454 -3746.633637 -1.320816 -3747.573719 -3748.894535 
C2 -3747.984457 -3746.620162 -1.379178 -3747.564755 -3748.943933 
C3 -3747.990155 -3746.608414 -1.391470 -3747.553749 -3748.945219 
N4 -3747.986162 -3746.594866 -1.402745 -3747.538944 -3748.941688 
C5 -3747.986090 -3746.579688 -1.424136 -3747.523829 -3748.947966 
C6 -3747.986334 -3746.560331 -1.432601 -3747.506884 -3748.939484 
C7 -3747.983956 -3746.559461 -1.427999 -3747.503215 -3748.931214 
C8 -3747.975012 -3746.552480 -1.426065 -3747.498051 -3748.924116 
C9 -3747.951588 -3746.541770 -1.439536 -3747.486551 -3748.926087 
C10 -3747.962989 -3746.544227 -1.444677 -3747.487310 -3748.931988 
N11 -3747.965594 -3746.545618 -1.434616 -3747.488386 -3748.923002 
C12 -3747.970630 -3746.568313 -1.439740 -3747.512162 -3748.951901 
S36 
C13 -3747.984963 -3746.566439 -1.426545 -3747.520090 -3748.946635 
N14 -3747.997611 -3746.586135 -1.420864 -3747.532033 -3748.952897 
C15 -3748.001689 -3746.591399 -1.420758 -3747.534899 -3748.955657 
C16 -3748.009065 -3746.597792 -1.405056 -3747.540877 -3748.945933 
Table S7. The energy components of CBPQT4+ moving on DB83+ with 2 Cl–(configuration 1) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -4208.344577 -4207.378152 -0.966425 -4208.379425 -4209.345850 
C2 -4208.358055 -4207.359675 -0.998380 -4208.360738 -4209.359118 
C3 -4208.353949 -4207.351684 -1.002265 -4208.353820 -4209.356085 
N4 -4208.359548 -4207.328584 -1.030964 -4208.333492 -4209.364456 
C5 -4208.352082 -4207.328762 -1.023319 -4208.335019 -4209.358338 
C6 -4208.351969 -4207.315437 -1.036532 -4208.323229 -4209.359761 
C7 -4208.349021 -4207.307683 -1.041338 -4208.314871 -4209.356209 
C8 -4208.344373 -4207.299377 -1.044995 -4208.306394 -4209.351389 
C9 -4208.344988 -4207.304264 -1.040724 -4208.311100 -4209.351824 
C10 -4208.358575 -4207.325293 -1.033283 -4208.331964 -4209.365247 
N11 -4208.362071 -4207.326534 -1.035537 -4208.332417 -4209.367954 
C12 -4208.352463 -4207.331863 -1.020600 -4208.338604 -4209.359203 
S37 
C13 -4208.363247 -4207.339074 -1.024173 -4208.344680 -4209.368854 
N14 -4208.379051 -4207.346382 -1.032669 -4208.351221 -4209.383890 
C15 -4208.379146 -4207.348612 -1.030534 -4208.353274 -4209.383809 
C16 -4208.381736 -4207.373363 -1.008374 -4208.376534 -4209.384908 
Table S8. The energy components of CBPQT4+ moving on DB83+ with 2 Cl–(configuration 2) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -4208.344932 -4207.403938 -0.940994 -4208.405109 -4209.346103 
C2 -4208.351621 -4207.390258 -0.961363 -4208.393501 -4209.354863 
C3 -4208.361373 -4207.377600 -0.983773 -4208.380335 -4209.364108 
N4 -4208.372490 -4207.360509 -1.011981 -4208.365245 -4209.377226 
C5 -4208.369254 -4207.342461 -1.026793 -4208.347906 -4209.374699 
C6 -4208.351805 -4207.318367 -1.033438 -4208.324691 -4209.358129 
C7 -4208.342178 -4207.313528 -1.028649 -4208.321986 -4209.350635 
C8 -4208.349002 -4207.306222 -1.042780 -4208.313462 -4209.356241 
C9 -4208.353965 -4207.304617 -1.049348 -4208.312405 -4209.361753 
C10 -4208.352116 -4207.311727 -1.040389 -4208.318346 -4209.358735 
N11 -4208.352689 -4207.314216 -1.038473 -4208.320762 -4209.359235 
C12 -4208.356528 -4207.333037 -1.023491 -4208.340115 -4209.363605 
S38 
C13 -4208.359308 -4207.339431 -1.019876 -4208.344686 -4209.364562 
N14 -4208.374895 -4207.343072 -1.031823 -4208.347765 -4209.379589 
C15 -4208.378811 -4207.348003 -1.030808 -4208.352280 -4209.383088 
C16 -4208.374978 -4207.365051 -1.009928 -4208.367407 -4209.377335 
Table S9. The energy components of CBPQT4+ moving on DB83+ with 3 Cl–(configuration 1) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -4668.670563 -4667.926512 -0.744051 -4668.987758 -4669.731808 
C2 -4668.692034 -4667.948030 -0.744004 -4669.010870 -4669.754874 
C3 -4668.696411 -4667.966856 -0.729555 -4669.032729 -4669.762284 
N4 -4668.708114 -4667.972124 -0.735990 -4669.039579 -4669.775570 
C5 -4668.704431 -4667.960150 -0.744281 -4669.028412 -4669.772692 
C6 -4668.703570 -4667.957238 -0.746332 -4669.026824 -4669.773156 
C7 -4668.699852 -4667.953018 -0.746834 -4669.022905 -4669.769739 
C8 -4668.703950 -4667.955866 -0.748084 -4669.025223 -4669.773307 
C9 -4668.702406 -4667.970373 -0.732034 -4669.038614 -4669.770648 
C10 -4668.717918 -4667.989332 -0.728586 -4669.058116 -4669.786702 
N11 -4668.711727 -4667.987387 -0.724340 -4669.055259 -4669.779599 
C12 -4668.707990 -4667.987683 -0.720307 -4669.057581 -4669.777888 
S39 
C13 -4668.700961 -4667.982158 -0.718803 -4669.052960 -4669.771763 
N14 -4668.695862 -4667.981650 -0.714212 -4669.050278 -4669.764489 
C15 -4668.710142 -4668.000267 -0.709875 -4669.067671 -4669.777546 
C16 -4668.738442 -4668.031843 -0.706599 -4669.096541 -4669.803140 
Table S10. The energy components of CBPQT4+ moving on DB83+ with 3 Cl–(configuration 2) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -4668.694627 -4668.031238 -0.663390 -4669.096383 -4669.759773 
C2 -4668.705877 -4668.031723 -0.674155 -4669.094609 -4669.768764 
C3 -4668.714858 -4668.033028 -0.681830 -4669.096524 -4669.778354 
N4 -4668.728000 -4668.026350 -0.701650 -4669.090137 -4669.791787 
C5 -4668.736651 -4668.020157 -0.716495 -4669.085408 -4669.801903 
C6 -4668.724337 -4668.006362 -0.717976 -4669.070693 -4669.788669 
C7 -4668.723167 -4668.007802 -0.715366 -4669.073514 -4669.788880 
C8 -4668.725131 -4668.005714 -0.719417 -4669.073466 -4669.792883 
C9 -4668.733565 -4668.016388 -0.717177 -4669.085789 -4669.802966 
C10 -4668.713336 -4668.000111 -0.713225 -4669.066846 -4669.780071 
N11 -4668.710112 -4667.995360 -0.714752 -4669.061923 -4669.776676 
C12 -4668.708123 -4667.986329 -0.721794 -4669.056142 -4669.777936 
S40 
C13 -4668.703208 -4667.986234 -0.716974 -4669.057039 -4669.774013 
N14 -4668.699105 -4667.992169 -0.706936 -4669.060309 -4669.767244 
C15 -4668.722671 -4668.000410 -0.722262 -4669.065067 -4669.787329 
C16 -4668.728823 -4668.019349 -0.709474 -4669.083801 -4669.793275 
 
Figure S12. The potential energy surface of CBPQT4+ moving on DB83+. These energies 
are enthalpies at 0K, except that we do not include zero point energy (the solvation 
correction is a free energy at 300K). The reference is at infinite separation. The energy of 
S41 
the rotaxane with CBPQT4+ optimized with no constraint at the end of diisopropylphenol 
is 14.4 kcal/mol, leading to the dethreading enthalpic barrier 18.7 kcal/mol. This can be 
compared to experimental dethreading free energy barrier of 28.5 kcal mol-1 for 
DB83+⊂CBPQT4+. The discrepancy probably arises because the theory does not include 
ZPE or entropic affects.  
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Table S11. The energy components of CBPQT4+ moving on DB93+ with no Cl– 
 
solution 
phase energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
DB9
3+
 -1757.202934 -1756.737549 -0.465385446 -1757.205813 -1757.671200 
freely 
optimized 
-3366.297002 -3364.692622 -1.604379 -3365.583946 -3367.188326 
C1 -3366.256609 -3364.569436 -1.687172 -3365.464766 -3367.151939 
C2 -3366.248275 -3364.506685 -1.741590 -3365.293463 -3367.035052 
C3 -3366.246115 -3364.486493 -1.759622 -3365.385346 -3367.144968 
N4 -3366.247019 -3364.447489 -1.799530 -3365.347336 -3367.146866 
C5 -3366.245675 -3364.431896 -1.813779 -3365.324066 -3367.137845 
C6 -3366.244950 -3364.421083 -1.823866 -3365.319231 -3367.143097 
C7 -3366.251536 -3364.404100 -1.847436 -3365.303069 -3367.150505 
C8 -3366.233153 -3364.406531 -1.826622 -3365.305730 -3367.132351 
C9 -3366.236909 -3364.406010 -1.830899 -3365.303678 -3367.134578 
C10 -3366.231492 -3364.407074 -1.824419 -3365.304049 -3367.128467 
N11 -3366.223617 -3364.407401 -1.816216 -3365.304864 -3367.121080 
C12 -3366.219384 -3364.405907 -1.813477 -3365.303340 -3367.116817 
C13 -3366.208671 -3364.401564 -1.807107 -3365.299409 -3367.106515 
C14 -3366.217241 -3364.420046 -1.797196 -3365.316810 -3367.114005 
C15 -3366.240196 -3364.439487 -1.800710 -3365.337140 -3367.137850 
N16 -3366.253825 -3364.467439 -1.786386 -3365.362689 -3367.149074 
C17 -3366.254024 -3364.474362 -1.779662 -3365.371612 -3367.151274 
C18 -3366.259237 -3364.491081 -1.768156 -3365.385847 -3367.154003 
C19 -3366.275421 -3364.518585 -1.756836 -3365.412665 -3367.169501 
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Table S12. The energy components of CBPQT4+ moving on DB93+ with 1 Cl–(configuration 1) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -3826.614312 -3825.360641 -1.253671 -3826.319661 -3827.573331 
C2 -3826.603324 -3825.305957 -1.297367 -3826.265339 -3827.562706 
C3 -3826.601705 -3825.271602 -1.330104 -3826.235048 -3827.565151 
N4 -3826.602025 -3825.251300 -1.350725 -3826.215420 -3827.566145 
C5 -3826.604911 -3825.244244 -1.360667 -3826.208640 -3827.569307 
C6 -3826.606000 -3825.225201 -1.380799 -3826.190727 -3827.571526 
C7 -3826.609218 -3825.215229 -1.393989 -3826.181742 -3827.575731 
C8 -3826.613981 -3825.205766 -1.408215 -3826.178899 -3827.587114 
C9 -3826.602980 -3825.198250 -1.404731 -3826.167722 -3827.572452 
C10 -3826.598444 -3825.200552 -1.397892 -3826.164879 -3827.562771 
N11 -3826.595411 -3825.199625 -1.395785 -3826.164986 -3827.560771 
C12 -3826.593172 -3825.210754 -1.382418 -3826.182247 -3827.564665 
C13 -3826.587090 -3825.206898 -1.380192 -3826.169078 -3827.549270 
C14 -3826.606684 -3825.241169 -1.365515 -3826.201287 -3827.566802 
C15 -3826.614165 -3825.251912 -1.362253 -3826.211863 -3827.574116 
N16 -3826.639110 -3825.276204 -1.362907 -3826.239320 -3827.602226 
C17 -3826.642040 -3825.279608 -1.362432 -3826.242846 -3827.605279 
C18 -3826.636257 -3825.281477 -1.354781 -3826.242482 -3827.597263 
C19 -3826.639460 -3825.291878 -1.347582 -3826.253239 -3827.600821 
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Table S13. The energy components of CBPQT4+ moving on DB93+ with 1 Cl–(configuration 2) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -3826.620456 -3825.343430 -1.277026 -3826.300619 -3827.577645 
C2 -3826.627213 -3825.325180 -1.302033 -3826.284104 -3827.586137 
C3 -3826.627039 -3825.302860 -1.324179 -3826.263236 -3827.587415 
N4 -3826.613317 -3825.252110 -1.361208 -3826.215927 -3827.577135 
C5 -3826.620803 -3825.238720 -1.382083 -3826.204989 -3827.587071 
C6 -3826.613103 -3825.221125 -1.391977 -3826.188087 -3827.580064 
C7 -3826.612357 -3825.215764 -1.396593 -3826.182125 -3827.578718 
C8 -3826.605756 -3825.205148 -1.400608 -3826.172040 -3827.572649 
C9 -3826.605380 -3825.195219 -1.410161 -3826.162059 -3827.572220 
C10 -3826.610283 -3825.208821 -1.401462 -3826.179167 -3827.580629 
N11 -3826.611839 -3825.208991 -1.402849 -3826.177801 -3827.580650 
C12 -3826.610917 -3825.225561 -1.385357 -3826.188247 -3827.573604 
C13 -3826.606051 -3825.227321 -1.378731 -3826.189675 -3827.568406 
C14 -3826.608081 -3825.243580 -1.364502 -3826.205656 -3827.570158 
C15 -3826.615778 -3825.252175 -1.363603 -3826.212390 -3827.575993 
N16 -3826.635267 -3825.269363 -1.365903 -3826.229497 -3827.595400 
C17 -3826.636989 -3825.276081 -1.360908 -3826.236686 -3827.597594 
C18 -3826.623536 -3825.278489 -1.345048 -3826.239144 -3827.584192 
C19 -3826.633095 -3825.292067 -1.341028 -3826.252559 -3827.593588 
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Table S14. The energy components of CBPQT4+ moving on DB93+ with 2 Cl–(configuration 1) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -4286.899305 -4285.956710 -0.942595 -4287.041869 -4287.984464 
C2 -4286.983289 -4286.019420 -0.963870 -4287.041869 -4288.005739 
C3 -4286.980750 -4286.016829 -0.963921 -4287.040125 -4288.004047 
N4 -4286.957737 -4285.968951 -0.988786 -4286.993111 -4287.981896 
C5 -4286.907198 -4285.919251 -0.987947 -4286.946505 -4287.934451 
C6 -4286.971718 -4285.967203 -1.004515 -4286.992011 -4287.996526 
C7 -4286.973406 -4285.961970 -1.011436 -4286.987487 -4287.998922 
C8 -4286.971407 -4285.959780 -1.011627 -4286.986086 -4287.997713 
C9 -4286.969351 -4285.956276 -1.013075 -4286.983260 -4287.996335 
C10 -4286.975694 -4285.963907 -1.011788 -4286.990521 -4288.002309 
N11 -4286.968782 -4285.961263 -1.007519 -4286.989351 -4287.996871 
C12 -4286.977218 -4285.979302 -0.997915 -4287.003749 -4288.001664 
C13 -4286.976385 -4285.979766 -0.996619 -4287.004298 -4288.000916 
C14 -4286.965867 -4285.976744 -0.989123 -4287.000805 -4287.989928 
C15 -4286.960510 -4285.977385 -0.983125 -4287.001161 -4287.984287 
N16 -4286.953110 -4285.977038 -0.976072 -4287.001724 -4287.977796 
C17 -4286.964922 -4285.983190 -0.981731 -4287.006944 -4287.988675 
C18 -4286.983461 -4285.995950 -0.987511 -4287.020131 -4288.007642 
C19 -4286.981202 -4286.005775 -0.975428 -4287.028937 -4288.004365 
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Table S15. The energy components of CBPQT4+ moving on DB93+ with 2 Cl–(configuration 2) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -4286.978759 -4286.059089 -0.919670 -4287.078379 -4287.998049 
C2 -4286.968313 -4286.026128 -0.942185 -4287.047979 -4287.990165 
C3 -4286.973893 -4286.017356 -0.956536 -4287.039764 -4287.996300 
N4 -4286.996055 -4285.984459 -1.011596 -4287.008728 -4288.020324 
C5 -4286.974522 -4285.970889 -1.003633 -4285.970894 -4286.974527 
C6 -4286.972788 -4285.965110 -1.007677 -4286.992320 -4287.999998 
C7 -4286.971369 -4285.961557 -1.009812 -4286.988049 -4287.997861 
C8 -4286.972085 -4285.958707 -1.013378 -4286.984942 -4287.998319 
C9 -4286.977769 -4285.962052 -1.015718 -4286.988930 -4288.004648 
C10 -4286.974173 -4285.959666 -1.014507 -4286.986743 -4288.001250 
N11 -4286.975777 -4285.959134 -1.016642 -4286.985803 -4288.002445 
C12 -4286.973659 -4285.967604 -1.006056 -4286.991683 -4287.997738 
C13 -4286.977459 -4285.974888 -1.002571 -4287.000449 -4288.003020 
C14 -4286.973653 -4285.987052 -0.986600 -4287.013059 -4287.999659 
C15 -4286.979360 -4285.994291 -0.985069 -4287.018949 -4288.004017 
N16 -4286.994025 -4285.998694 -0.995331 -4287.022888 -4288.018218 
C17 -4286.997505 -4286.009125 -0.988380 -4287.034257 -4288.022637 
C18 -4286.986438 -4286.009549 -0.976889 -4287.032714 -4288.009604 
C19 -4286.980333 -4286.011242 -0.969090 -4287.034107 -4288.003197 
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Table S16. The energy components of CBPQT4+ moving on DB93+ with 3 Cl–(configuration 1) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -4747.299122 -4746.585479 -0.713643 -4747.665389 -4748.379032 
C2 -4747.303507 -4746.611357 -0.692150 -4747.698916 -4748.391066 
C3 -4747.308462 -4746.621592 -0.686871 -4747.706967 -4748.393838 
N4 -4747.319485 -4746.600398 -0.719087 -4747.687947 -4748.407034 
C5 -4747.331646 -4746.595618 -0.736029 -4747.684360 -4748.420389 
C6 -4747.323395 -4746.606234 -0.717161 -4747.694648 -4748.411809 
C7 -4747.329184 -4746.609540 -0.719643 -4747.697638 -4748.417281 
C8 -4747.332382 -4746.612188 -0.720194 -4747.700471 -4748.420665 
C9 -4747.331138 -4746.624271 -0.706866 -4747.712436 -4748.419302 
C10 -4747.331294 -4746.625013 -0.706281 -4747.714167 -4748.420448 
N11 -4747.331105 -4746.623613 -0.707492 -4747.712219 -4748.419711 
C12 -4747.324684 -4746.631108 -0.693576 -4747.718225 -4748.411801 
C13 -4747.397243 -4746.631009 -0.766233 -4747.717591 -4748.483824 
C14 -4747.324237 -4746.634363 -0.689874 -4747.722900 -4748.412774 
C15 -4747.321343 -4746.623604 -0.697739 -4747.707928 -4748.405667 
N16 -4747.323576 -4746.635723 -0.687852 -4747.721061 -4748.408913 
C17 -4747.339455 -4746.641968 -0.697488 -4747.727350 -4748.424838 
C18 -4747.336555 -4746.642783 -0.693772 -4747.727896 -4748.421669 
C19 -4747.344468 -4746.648070 -0.696399 -4747.732464 -4748.428863 
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Table S17. The energy components of CBPQT4+ moving on DB93+ with 3 Cl–(configuration 2) 
 
solution phase 
energy 
gas phase 
energy 
solvation 
energy 
refined single 
point energy 
total energy 
C1 -4747.332354 -4746.694656 -0.637698 -4747.777299 -4748.414997 
C2 -4747.332570 -4746.675578 -0.656992 -4747.759394 -4748.416386 
C3 -4747.336101 -4746.661357 -0.674744 -4747.744694 -4748.419438 
N4 -4747.342079 -4746.658042 -0.684037 -4747.742471 -4748.426508 
C5 -4747.342049 -4746.652809 -0.689240 -4747.738137 -4748.427377 
C6 -4747.332367 -4746.634212 -0.698156 -4747.717199 -4748.415354 
C7 -4747.331877 -4746.632574 -0.699303 -4747.718283 -4748.417587 
C8 -4747.335836 -4746.630539 -0.705297 -4747.719054 -4748.424351 
C9 -4747.338420 -4746.635898 -0.702522 -4747.723763 -4748.426286 
C10 -4747.330895 -4746.621605 -0.709290 -4747.707952 -4748.417242 
N11 -4747.339561 -4746.620564 -0.718998 -4747.708176 -4748.427174 
C12 -4747.328516 -4746.618773 -0.709743 -4747.705799 -4748.415542 
C13 -4747.313837 -4746.615060 -0.698777 -4747.703730 -4748.402506 
C14 -4747.309448 -4746.611161 -0.698287 -4747.699416 -4748.397703 
C15 -4747.322918 -4746.614607 -0.708312 -4747.702723 -4748.411035 
N16 -4747.349148 -4746.631216 -0.717931 -4747.717660 -4748.435591 
C17 -4747.353127 -4746.635592 -0.717536 -4747.722772 -4748.440308 
C18 -4747.348807 -4746.637300 -0.711508 -4747.721239 -4748.432747 
C19 -4747.345710 -4746.635897 -0.709813 -4747.717481 -4748.427293 
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Figure S13. The potential energy surface of CBPQT4+ moving on DB93+. These energies 
are enthalpies at 0K, except that we do not include zero point energy (the solvation 
correction is a free energy at 300K). The reference is at infinite separation. The energy of 
the rotaxane with CBPQT4+ optimized with no constraint at the end of diisopropylphenol 
is 15.8 kcal/mol, leading to the dethreading barrier 12.4 kcal/mol. There are no 
experimental numbers for the dethreading of this system. However based on the 
comparison of theory and experiment for DB83+⊂CBPQT4+ (see Figure S12) we estimate 
that the free energy barrier for DB93+⊂CBPQT4+.is ~ 22.2 kcal mol-1. The discrepancy 
probably arises because the theory does not include ZPE or entropic affects. 
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7. Calculation of Energy Conversion Efficiency 
Pumping one CBPQT4+ from solution to a high energy state involves a three electron reduction 
process with Zn followed by a three electron oxidization process with Magic Blue. 
 
Figure S14. Energy change illustration in redox process. 
 
The energy change in redox process can be calculated by the following equation, where n is the 
number of electrons transferred, EZn/Zn(II) and EMB are the reduction potentials for zinc and Magic 
Blue8, respectively (concentration dependency is ignored for this rough calculation), and F is 
Faraday’s constant. 
 
∆G1 =  ̶ nEZn/Zn(II)F = 3 × ( ̶ 0.76 V) × 9.65 × 10
4 C mol-1 / (4184 J kcal-1) = 52.6 kcal mol-1 
∆G2 = nEMBF = 3 × 1.22 V × 9.65 × 10
4 C mol-1 / (4184 J kcal-1) = 84.4 kcal mol-1 
 
So the total energy input can be calculated as follow, 
 
∆Gin  =  ∆G1 + ∆G2  = 137.0 kcal mol
-1 
 
 
Figure S15. Energy profile for the metastable state. 
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Table S18. Summary of Energy Output and Energy Conversion Efficiency. 
Species 
DFT Calculated 
∆H / kcal mol-1 
∆G≠  
 kcal mol-1 
∆G≠0
  
kcal mol-1 
∆G c 
kcal mol-1 
η
 d
 
% 
CBPQT
4+
⊂DB1
3+
 14.9 21.5 36 a 14 10 
CBPQT
4+
⊂DB2
3+
 8.8 25.3 36 a 11 8 
CBPQT
4+
⊂DB3
3+
 7.0 29.0 36 a 7 5 
CBPQT
4+
⊂DB4
3+
 - 24.5 36 a 12 9 
CBPQT
4+
⊂DB5
3+
 - - 36 a - - 
CBPQT
4+
⊂DB6
3+
 - < 18.3 - - - 
CBPQT
4+
⊂DB7
3+
 - > 31.3 43 b - - 
CBPQT
4+
⊂DB8
3+
 - 28.5 43 b 14 10 
a Estimated based on DFT calculated ∆H for CBPQT4+⊂DB1-33+ and experimental ∆G≠ 
considering T∆S is a small negative number. b Estimated based upon the experimentally observed 
increase of 7 kcal mol-1 in activation barrier upon changing a propethylene linker between the 
PY
+ and BIPY2+ units to a bismethylene linker (DB13+ to DB83+) and making the assumption that 
their T∆S is similar. c Calculated using ∆G = ∆G≠0 - ∆G
≠. d Calculated using η = ∆G / ∆Gin. 
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